chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A week after the shot; a red whelp appeared around injection shot along with a rash on legs, hands and arm
Unexplained death - under investigation.  3/19/08 Autopsy report states microscopic exam of lung tissue revealed interstitial mononuclear inflammatory infiltrates & occasional multi-nucleated giant cells c/w pneumonia of viral etiology.
Child's mom calls on 05/24/2021.  States her daughter developed a rash to her torso and had a fever of 101.0 F post vaccination.  States they visited her physician today and their physician said it looked like a viral rash, but, recommended calling and reporting the event to the health department (VAERS Reporter).   Went to physician office to get started on birth control.  Mom says she just decided to mention the rash to the physician, but, wasn't concerned.
was burning up; certain parts of his body were hot like stomach and back; still feels achy; run down; had chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Mar-2021 and was forwarded to Moderna on 30-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (was burning up), FEELING HOT (certain parts of his body were hot like stomach and back), PAIN (still feels achy), FEELING ABNORMAL (run down) and CHILLS (had chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BURNING SENSATION (was burning up), FEELING HOT (certain parts of his body were hot like stomach and back), PAIN (still feels achy), FEELING ABNORMAL (run down) and CHILLS (had chills). At the time of the report, BURNING SENSATION (was burning up), FEELING HOT (certain parts of his body were hot like stomach and back), PAIN (still feels achy), FEELING ABNORMAL (run down) and CHILLS (had chills) outcome was unknown.            No concomitant medication provided. Patient received Tylenol treatment for the symptoms.  Patient has registered for Vsafe.   Reporter did not allow further contact
Large raised, red, blotchy - larger than palm of mom's hand. Warm. No Fever.
Unsteady gait began 2/20/21 and with physical therapy improved dramatically over 2-1/2 months and has resolved about 92% currently. On 2/22/21 the facial tingling in the lower right side of my face started. Over a couple of months, that symptom resolved with the exception of the right side of the tongue which still has tingling. The diplopia started on 2/26/21 and resolved completely within three weeks with no treatment.
I was sent to 15 minute waiting area and started to feel a sense of warmth come over my body.  I raised my hand.  I told the attendant I was feeling ill and weak.  Next thing I knew I was waking up on the floor with EMT and medical professionals trying to get me to come back to.
Started as itchy right wrist, then became red itchy burning rash on lower right torso, then eye sty and mouth sore
Sever chills Extreme tightness in chest muscle?s that lasted 4 hours for two nights in a row
Pt given Proquad, IPV vaccines; within 10 minutes pt experienced coughing spells, watery eyes and itching in extremities: pt had mild and expiratory wheezing on respiration. Given Zyrtec antihistamine and promptly sent to E.R. where he received steroids and I.V.  Benadryl. He was observed in ER and 3 hours and D/C'D home: Pt continued to do well over weekend.
Hib#1 given to left thigh without difficulty at 0930.  Patient very fussy at 1000.  Redness with swelling of feet at 1230.  Placed in cooling bath and massaged better at 1300.  Here in clinic at 1400, no redness or swelling.
Hospitalization due to COVID in a fully vaccinated individual:  Vaccinated on 4/1/21 and 3/7/21 with Moderna vaccine.
Extreme pain in arm. Could not lift arm for 3 days. Stomach upset, vomiting. Body aches and full body weakness.
Patient on awakening this AM had a HA (short duration) and facial droop.  These symptoms alarmed him enough to present to the ED at an outside hospital.  Diagnosis of Bell's Palsy is made with treatment of antivirals and steroids.
Dizziness; BP 154/48, pulse 75; BP 147/53, pulse 76. EKG showed sinus tachycardia with PVC's, right BBB. Sent to ED.
PT SEEN IN OFFICE ON 2/8/08 FOR RED SPOT/BUMP ON LEG FOLLOWING SHOTS GIVEN 1/25/08. MD NOTED AREA ON RT LATERAL THIGH 0.75 X 1.5 CM OF SUPERFICIAL REDNESS, NO INDURATION, NO FLUCTUATION, NO PAIN. MD DXED MINOR LOCAL REACTION TO VACCINE AND RXED BACTROBAN OINTMENT TO BE APPLIED 5 TIMES/DAY UNTIL SKIN CLEAR FOR 24 HRS.
tested positive for COVID-19 at dr's office approximately 1 week before being seen in the ED; presents to ED with SOB and is hypoxic, with runny nose, sore throat, headache, and cough; hx of COPD, placed on a ventilator; condition worsened; pt passed away in hospital
This spontaneous report was received from a 66 year old male patient regarding himself. The patient's medical history included Raynaud's phenomenon (the patient stated that this was 'stems from Guillain-Barre syndrome'). Patient didn't have any drug allergies or reactions. On 13-OCT-2015, the patient was vaccinated with PNEUMOVAX 23 shot (strength, dose, route and lot number or batch number unspecified). No information on concomitant medication was provided. The patient reported that over a period of two to three days (since an unknown date approximately in October 2015) after receiving PNEUMOVAX 23, his Guillain-Barre syndrome symptoms gradually "revived". These symptoms included severe foot tingling, loss of reflexes, anxiety attacks in the form of a racing heart and night sweats. The patient did not seek any medical attention. The outcome of the event and causality were unknown. No further information was available. No product quality complaint (PQC) was involved. Upon internal review, the event Guillain-Barre syndrome was determined to be medically significant. Additional information has been requested.
ACUTE RESPIRATORY FAILURE 1/22/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Extreme exhaustion; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 08Feb2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included levothyroxine sodium (SYNTHROID), fish oil (MANUFACTURER UNKNOWN), vitamin D nos (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN) from an unknown date for unknown indication. The patient had no allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302) via an unspecified route of administration in the left arm on 18Jan2021.Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Feb2021, the patient experienced extreme exhaustion. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event extreme exhaustion was resolved at the time of reporting.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On an unknown dates, the patients were vaccinated with an improperly stored dose of GARDASIL (lot# K005881 with expiration date 14-JAN-2017; dose, anatomical location and route of administration were not reported). The vaccines were exposed to 4 hours 30 minutes at 47.5 Fahrenheit (F) on the fifth of April (year unspecified), 1 hour 30 minutes at 51.3 F, 2 hours at 56.3 F on the seventh of April (year unspecified), 1 hour and 30 minutes at 48.9 F on the fifth of May (year unspecified) and 1 hours at 51.6 F on the sixth of May (year unspecified). No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient was given vaccine 3 weeks post vaccine expiration date. No physical symptoms or adverse reactions experienced by patient.
I tested positive for COVID on 10/14/2021, but I had COVID symptoms before that for about a week. I had congestion, brain fog, muscle weakness, and racing heart. The heart racing has not stopped. Other symptoms lasted a good two weeks.
We could not get in touch with the patient mother via phone . letter mailed out to the home. Pt c mild swelling to her R arm.  Mom thought Regular reaction.
non-stop Tachycardia began at 8:00 pm; left arm near injection site was red, swollen, tender to touch.  Went to ER at around 0100 on 7/8/23 for tachycardia at 137 bpm where I was given medicine to slow my heart rate down. Red, swollen, and soreness for several inches around my injection site and continued for days.  As of today 7/10/23 it is still red and slightly less tender.
t103 couldn't sit up; couldn't lift up, pale, limp, excessive crying-fever med didn't help problems lasted several days; not seen by MD;
Two hours after the injected vaccine I feel metallic taste in my mouth. It's been 27 days and I still have it.
lights and sounds mildly affected me/After that dose, lights as well as sound started to get worse for me; lights and sounds mildly affected me/After that dose, lights as well as sound started to get worse for me; lights and sounds mildly affected me/After that dose, lights as well as sound started to get worse for me; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 29-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Jan2022 10:30 (Lot number: FE3594) at the age of 29 years as dose 1, single for COVID-19 immunization. Relevant medical history included: "Epilepsy" (unspecified if ongoing); "Covid-19", start date: Sep2021 (unspecified if ongoing); "Since then lights and sounds mildly affected me" (unspecified if ongoing), notes: but not enough to hinder my day to day routine. The patient had no known allergies. Concomitant medication included: DILANTIN [PHENYTOIN]. The following information was reported: PHOTOPHOBIA (disability), HYPERACUSIS (disability), CONDITION AGGRAVATED (disability), outcome "unknown" and all described as "lights and sounds mildly affected me/After that dose, lights as well as sound started to get worse for me". Patient reported that, "I was positive for COVID-19 in the end of Sep2021. Since then lights and sounds mildly affected me but not enough to hinder my day to day routine. I received my first dose of Pfizer in Jan2022. After that dose, lights as well as sound started to get worse for me however I was still able to work out and go to work as usual." The patient was not tested for COVID, post vaccination.
Mother states child had seizure in car on the way home from receiving vaccines. She says the child became rigid, pale, diaphoretic, and unresponsive for approximately 15-20 seconds. Child was taken to ER and physician stated that this was an atypical reaction to these vaccines.
Hives on arm, abdomen, and groin developed within 24h after 1st dose of vaccine.
This spontaneous report was received from a Certified Medical Assistant (C.M.A) concerning a 4 month old infant. No concurrent conditions or medical history were reported. On 10-AUG-2015, the patient was vaccinated with the first dose of (Oka/Merck) VARIVAX (dose, route, Lot No. and anatomical location of administration were not reported). No adverse symptoms reported. No Product Quality Complaint (PQC) was involved. Additional information has been requested.
Patient called 9-15, reported itching, redness about 4 inches appearing one evening at the injection site after receiving the ZOSTAVAX given 9-11-09.
This case was reported by a consumer via literature and described the occurrence of influenza in an elderly male subject who was vaccinated with Influenza vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. Concurrent medical conditions included ingrown hair. Co-suspect medication included ADVAIR multi dose powder inhaler and Albuterol. Concurrent medications included antibiotics and Oxygen. On unknown dates, the patient started Fluticasone propionate+salmeterol xinafoate (unknown), unknown dosing. In November or December 2012 the subject received unspecified dose of Influenza vaccine unspecified (unknown). At an unknown time after starting Fluticasone propionate+salmeterol xinafoate and Albuterol, and approximately, three months after vaccination with Influenza vaccine unspecified, the subject experienced influenza, vaccination failure, weakness, hard to breath, heavy cough and blood oxygen really drops [low oxygen saturation aggravated]. The subject reported "I got a flu shot some months back, I think maybe November/December some time, but it only goes to show you that even the flu vaccination doesn't always work, because I'm battling it right now, very weak, hard to breathe, heavy coughing, but no fever. This last couple days it seems the more I lie down the more my blood oxygen goes down. When I have a bowel movement under normal circumstance my blood oxygen drops, but now it really drops so I have to be especially careful when I go. I glad that I'm in a nursing home right now, but they always can't do much for you. Fortunately I started antibiotic on Friday for a different related problem, an infected ingrown hair on my but...LOL. Hopefully it will help both ways, my doctor won't be back until Monday to do anything for me, like ROXYNAL for air starvation, I now have my oxygen at 5 units and it makes my canulas tubing at my nose soooo loud I can't stand it. This is the type flu that scares me, because it can easily take my life." This case was assessed as medically serious by GSK. At the time of reporting the influenza, weakness, hard to breath, heavy cough and low oxygen saturation aggravated were unresolved.
Soreness in arm; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm left on 23Mar2021 at 15:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included sucralfate (MANUFACTURER UNKNOWN), trilomarzia (MANUFACTURER UNKNOWN) and pantoprazole (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021, the patient experienced soreness in arm where vaccine was administered, could not sleep on that side for 4-5 nights, had soreness for about a week, but did not keep the patient from her normal routine and did not keep her from working. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event soreness in arm was recovered from an unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Within minutes of patient receiving her first dose on Pfizer Covid-19 she became limp and her head fell on her mother's shoulder. Her mother stated she was having a seizure. When the pharmacist came to her, she was conscience and alert. She stated she felt weak and she was given some water. EMS then arrived and she did not leave with EMS. She left with her mother who stated the next day that she immediately took her to ER where it was determined she had "an allergic reaction."
Exactly 7 days after injection, the injection site became red, swollen, warm to the touch, itchy. By the next day, the redness and swelling had spread all the way down my arm, almost to my elbow. I began taking ibuprofen and benadryl at this time. Swelling and redness receded gradually over the next 2 days.
5th day after 2nd dose: lymph  nodes swollen on right side from neck down through leg. Right arm swollen.  Nodes continue to be swollen,  tender and painful on day 20. Right arm swelling mostly gone.  Fever, fatigue, headaches lasted to day 13. Went to wellnow on day 5.  Going to see doctor today
No additional AE/No PQC.; Pharmacy technician called to report a T/E and it was reported that VARIVAX that was improperly stored was administered to a patient on 6-JUN-2023. Denies side effects or symptomatic events. No additional AE/No PQC.         ?    Names of vaccines i; Information has been received from a pharmacy technician, referring to a 38 year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 06-JUN-2023, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # reported as "X00100, with expiration date on 09-JAN-2025" subcutaneous injection (strength, route of administration, and anatomical location were not reported) for prophylaxis. No adverse effects were reported.   The vaccine had a temperature excursions of 24 hours with a lowest recorded temperature of 39 Fahrenheit (F).It was confirmed that no previous excursions occurred.  Lot number X00100 is an invalid lot number for varicella virus vaccine live (oka/merck) (VARIVAX).
Pt. went and purchased medication at pharm. and brought over here for administration. Pt came, V/S taken 98 degrees 73 20 116/64 98% at approx 11:50A vaccine given in (L) arm SQ approx 12N pt c/o starting to itch. Dr. notified V-O BENADRYL 25mg IM. Pt itching on (L) arm and numerous places on body. BENADRYL given in (R) buttock.
Injection site very sore, warm to the touch, painful, red, and some swelling: patient experienced pain on the upper arm to the neck and to her ear.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Headache-Mild, Systemic: Tinnitus-Mild, Additional Details: Patient briefly passed out 6-7 minutes after receiving vaccine. She appeared to have a 20 to 30 second seizure(later confirmed from emt that it is possible for that to happen with syncope. Patient was walked out of pharmacy by EMTs and taken to hospital for evaluation. There are no further up details at this point. I will follow up with parents and pateint tomorrow as this vaccine was given late at night.
C/o feeling dizzy, shaky, & increased heart rate about 60" after immunization on 11/17. Evaluated by Dr today Dx: allergic reaction, exam WNL & discharged.
increased temp w/in two hours of vaccines, parents unable to get temp to come down, parents brought pt to ED where seizure occurred. Seizure lasted 2-3 minutes, pt recovered after an hour.
body aches and chills 12/16/21. Presented to ED 12/17/21 for chest pain too.  EKG abnormal, thus workup initiated below. Ultimately transferred to higher level of care facility for myocarditis.
Light fever and irritability, Rash over back, palms and dorsal of hands, moving to lips and face, then to inside the mouth in cheeks and on tongue, persisting on lips for 10 days.
Upon getting the injection my teeth started aching and my stomach started burning.  The next day I have muscle pain, weakness and burning from the neck down.  Trouble raising my arms hurts to sit and my stomach is still painful the next day.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 09-MAR-2017, the patient was vaccinated with an expired dose of ZOSTAVAX vial (strength, dose, and route were not reported) (lot number L044529, expiration date: 09-FEB-2017) for prophylaxis. No adverse effects were reported. Additional information has been requested.
Patient claims she felt dizzy after vaccination and lost consciousness near checkout lane approximately 10 minutes after vaccination. She was assisted by asset protection staff and pharmacy staff. She left the store under her own power. She reported that she has had headaches and dizziness after the vaccination and was seen at an urgent care that did not provider her with a diagnosis, but felt her symptoms may have been caused by a concussion. She was advised by clinical team to contact her primary care doctor to follow-up, especially with recent reports of thrombosis linked with the J&J vaccine.
24 hours after: Mild fever 99.7, sneezing u controllably, flu like symptoms enough to make me leave work.   Sore arm. Slightly warm to touch, small bruise of injection site about the size of a dime.   Took Tylenol to assist with symptoms   48 hours after: Exhausted. Flu like symptoms continue.  Took Tylenol.   72 hours: Flu like symptoms almost gone completely but still exhausted. Arm still had bruise but not bad. Able to return to work.   10 days after: redness and warm to touch   11 days after: redness increasing about 2 inches   12 days after: red circle developed, grew in size to 3 inches around injection site. Sore and red and hot to touch.
A report was received from an observational study. This is a safety study using Adenovirus Type 4 and Type 7 Vaccine, Live, Oral. There were 55,989 in the exposed cohort and 55,989 in the unexposed cohort. The date of the surveillance of the exposed group was Oct 2011 to July 2012. The date of the surveillance of the unexposed group was Oct 2010 to July 2011. Of the 55,989 patients exposed, 2 patients experienced RASH and were hospitalized. Of the 55,989 patients unexposed, 7 patients experienced RASH and were hospitalized. Of the exposed patients who experienced serious RASH, 2 were in the 19-24 year age range, 2 were male. Of the 7 unexposed patients who experienced serious RASH, 1 was age 18; 6 were in age group 19-24; 1 female 6 male.